French ophthalmology company Nicox and Chinese firm Ocumension Therapeutics said on Monday they had signed an exclusive license agreement to develop and sell a yet-to-be approved Nicox drug to treat glaucoma in China.
from Reuters: Health News https://ift.tt/2S6qxLM
via IFTTT
from Reuters: Health News https://ift.tt/2S6qxLM
via IFTTT
إرسال تعليق